Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis

An Bras Dermatol. 2021 Jul-Aug;96(4):502-504. doi: 10.1016/j.abd.2021.02.002. Epub 2021 May 15.

Authors

Daniel Holanda Barroso¹, Ciro Martins Gomes², Antônia Marilene da Silva², Raimunda Nonata Ribeiro Sampaio³

Affiliations

¹ Universidade de Brasília, Brasília, DF, Brazil. Electronic address: Danielhbarroso@unb.br.
² Universidade de Brasília, Brasília, DF, Brazil.
³ Universidade de Brasília, Brasília, DF, Brazil; Hospital Universitário de Brasília, Universidade de Brasília, Brasília, DF, Brazil.

No abstract available

MeSH terms

Antiprotozoal Agents* / adverse effects
Cardiotoxicity / drug therapy
Humans
Leishmaniasis, Cutaneous* / drug therapy
Leishmaniasis, Mucocutaneous*
Leishmaniasis, Visceral* / drug therapy
Phosphorylcholine / adverse effects
Phosphorylcholine / analogs & derivatives
United States

Substances

Antiprotozoal Agents
Phosphorylcholine
miltefosine